Innova Captab

Innova Captab Book Value per Share

The Book Value per Share of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is 190.63 INR. In the previous year, Book Value per Share was 167.67 INR — a change of 13.69% (higher).

Book Value per Share

190.63INR

YoY

13.69%

Last updated:

Book Value per Share of Innova Captab is 2026 190.63 INR. Book Value per Share of Innova Captab was 2025 167.67 INR. It decreases by 13.69% higher compared to the previous year.

The Innova Captab Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2019
5.33 INR
Jan 1, 2020
13.33 INR
Jan 1, 2021
25.31 INR
Jan 1, 2022
36.46 INR
Jan 1, 2023
48.32 INR
Jan 1, 2024
145.21 INR
Jan 1, 2025
167.67 INR
Jan 1, 2026
190.63 INR
The Innova Captab Book Value per Share history
YEARBook Value per ShareYoY
190.63INR+13.69%
167.67INR+15.47%
145.21INR+200.50%
48.32INR+32.55%
36.46INR+44.04%
25.31INR+89.91%
13.33INR+149.93%
5.33INR-51.27%
10.94INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innova Captab stock

Book Value per Share of Innova Captab is 190.63 INR in 2026.

Book Value per Share of Innova Captab changed from 167.67 INR to 190.63 INR, representing a 13.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Innova Captab since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Innova Captab

All Key Metrics — Innova Captab